Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-26T13:15:20.511Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of Optimized Antibiotic Prophylaxis on the Incidence of Surgical Site Infection

Published online by Cambridge University Press:  21 June 2016

Judith Manniën ,
Marjo E. E. van Kasteren ,
Nico J. Nagelkerke ,
Inge C. Gyssens ,
Bart Jan Kullberg ,
Jan C. Wille  and
Annette S. de Boer
Judith Manniën*
Affiliation:
National Institute for Public Health and the Environment, Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven, The Netherlands
Marjo E. E. van Kasteren
Affiliation:
Department of Medicine, Radboud University Nijmegen Medical Centre, andNijmegen University Center for Infectious Diseases, Nijmegen, The Netherlands
Nico J. Nagelkerke
Affiliation:
National Institute for Public Health and the Environment, Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven, The Netherlands
Inge C. Gyssens
Affiliation:
Department of Medical Microbiology and Infectious Diseases and the Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
Bart Jan Kullberg
Affiliation:
Department of Medicine, Radboud University Nijmegen Medical Centre, andNijmegen University Center for Infectious Diseases, Nijmegen, The Netherlands
Jan C. Wille
Affiliation:
Dutch Institute for Healthcare Improvement CBO, Utrecht, The Netherlands
Annette S. de Boer
Affiliation:
National Institute for Public Health and the Environment, Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven, The Netherlands
*
National Institute for Public Health and the Environment, Center for Infectious Disease Epidemiology, PO Box 1, 3720 BA Bilthoven, The Netherlands (Judith.Mannien@rivm.nl)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To compare the rate of surgical site infection (SSI) before and after an intervention period in which an optimized policy for antibiotic prophylaxis was implemented. To demonstrate that a more prudent, restrictive policy would not have a detrimental effect on patient outcomes.

Design.

Before-after trial with prospective SSI surveillance in the Dutch nosocomial surveillance network (Preventie Ziekenhuisinfecties door Surveillance [PREZIES]), using the criteria of the Centers for Disease Control, including postdischarge surveillance for up to 1 year.

Methods.

During a preintervention period and a postintervention period (both 6-13 months), 12 Dutch hospitals collected data on antimicrobial prophylaxis and SSI rates. The study was limited to commonly performed surgical procedures in 4 specialties: vascular, intestinal, gynecological and orthopedic surgery. Selected risk factors for analysis were sex, age, American Society of Anesthesiologists classification, wound contamination class, duration of surgery, length of hospital stay before surgery, and urgency of surgery (elective or acute).

Results.

A total of 3,621 procedures were included in the study, of which 1,668 were performed before the intervention and 1,953 after. The overall SSI rate decreased from 5.4% to 4.5% (P = .22). Among the procedures included in the study, the largest proportion (55%) were total hip arthroplasty, and the smallest proportion (2%) were replacement of the head of the femur. SSI rates varied from 0% for vaginal hysterectomy to 21.1% for femoropopliteal or femorotibial bypass surgery. Crude and adjusted odds ratios showed that there were no significant changes in procedure-specific SSI rates after the intervention (P>.1).

Conclusions.

An optimized and restrictive antibiotic prophylaxis policy had no detrimental effect on the outcome of clean and clean contaminated surgery, as measured by SSI rate.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 27 , Issue 12 , December 2006 , pp. 1340 - 1346
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Mangram, AJ, Horan, TC, Pearson, ML, Silver, LC, Jarvis, WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27:97–132.Google Scholar
2. Weinstein, RA. Nosocomial infection update. Emerg Infect Dis 1998; 4:416–420.Google Scholar
3. Kirkland, KB, Briggs, JP, Trivette, SL, Wilkinson, WE, Sexton, DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20:725–730.Google Scholar
4. Geubbels, EL, Mintjes-de Groot, AJ, van den Berg, JM, de Boer, AS. An operating surveillance system of surgical-site infections in The Netherlands: results of the PREZIES national surveillance network. Preventie van Ziekenhuisinfecties door Surveillance. Infect Control Hosp Epidemiol 2000;21:311–318.Google Scholar
5. Bernard, HR, Cole, WR. The prophylaxis of surgical infection: the effect of prophylactic antimicrobial drugs on the incidence of infection following potentially contaminated operations. Surgery 1964; 56:151–157.Google ScholarPubMed
6. Polk, HC Jr, Lopez-Mayor, JF. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery 1969; 66:97–103.Google Scholar
7. Stone, HH, Hooper, CA, Kolb, LD, Geheber, CE, Dawkins, EJ. Antibiotic prophylaxis in gastric, biliary and colonic surgery. Ann Surg 1976; 184:443–452.Google Scholar
8. Hill, C, Mazas, F, Flamant, R, Evrard, J. Prophylactic cefazolin versus placebo in total hip replacement: report of a multicentre double-blind randomised trial. Lancet 1981; 317:795–797.Google Scholar
9. Grossman, JH 3rd, Greco, TP, Minkin, MJ, Adams, RL, Hierholzer, WJ Jr, Andriole, VT. Prophylactic antibiotics in gynecologic surgery. Obstet Gynecol 1979; 53:537–544.Google Scholar
10. Polk, BF, Tager, IB, Shapiro, M, Goren-White, B, Goldstein, P, Schoenbaum, SC. Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet 1980; 315:437–441.Google Scholar
11. Craig, WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26:1–10.Google Scholar
12. Bratzler, DW, Houck, PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706–1715.Google Scholar
13. McGowan, JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983; 5:1033–1048.Google Scholar
14. Harbarth, S, Samore, MH, Lichtenberg, D, Carmeli, Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101:2916–2921.Google Scholar
15. Martone, WJ, Nichols, RL. Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis 2001; 33(Suppl 2):S67–S68.Google Scholar
16. McGowan, JE Jr. Cost and benefit of perioperative antimicrobial prophylaxis: methods for economic analysis. Rev Infect Dis 1991; 13(Suppl 10):S879–S889.Google Scholar
17. Gyssens, IC, Geerligs, IE, Dony, JM, et al. Optimising antimicrobial drug use in surgery: an intervention study in a Dutch university hospital. J Antimicrob Chemother 1996; 38:1001–1012.Google Scholar
18. Classen, DC, Evans, RS, Pestotnik, SL, Horn, SD, Menlove, RL, Burke, JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326:281–286.Google Scholar
19. Burke, JP. Maximizing appropriate antibiotic prophylaxis for surgical patients: an update from LDS Hospital, Salt Lake City. Clin Infect Dis 2001; 33(Suppl 2):S78–S83.Google Scholar
20. van Kasteren, ME, Kullberg, BJ, de Boer, AS, Mintjes-de Groot, J, Gyssens, IC. Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals. J Antimicrob Chemother 2003; 51:1389–1396.Google Scholar
21. van Kasteren, ME, Mannien, J, Kullberg, BJ, et al. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis. J Antimicrob Chemother 2005; 56:1094–1102.Google Scholar
22. van Kasteren, ME, Gyssens, IC, Kullberg, BJ, Bruining, HA, Stobberingh, EE, Goris, RJ. Optimizing antibiotics policy in the Netherlands. V. SWAB guidelines for perioperative antibiotic prophylaxis. Foundation Antibiotics Policy Team [in Dutch]. Ned Tijdschr Geneeskd 2000; 144:2049–2055.Google Scholar
23. Wong, ES. Surgical site infections. In: Mayhall, CG, ed. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2004:287–310.Google Scholar
24. Altemeier, WA, Burke, JF, Pruitt, BA, Sandusky, WR. Manual on Control of Infection in Surgical Patients. 2nd ed. Philadelphia: JB Lippincott; 1984.Google Scholar
25. Owens, WD, Felts, JA, Spitznagel, EL Jr. ASA physical status classifications: a study of consistency of ratings. Anesthesiology 1978; 49:239–243.Google Scholar
26. Haley, RW, Culver, DH, White, JW, Morgan, WM, Emori, TG. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol 1985; 121:159–167.Google Scholar
27. Mishriki, SF, Law, DJ, Jeffery, PJ. Factors affecting the incidence of postoperative wound infection. J Hosp Infect 1990; 16:223–230.Google Scholar
28. Consensus paper on the surveillance of surgical wound infections. The Society for Hospital Epidemiology of America; The Association for Practitioners in Infection Control; The Centers for Disease Control; The Surgical Infection Society. Infect Control Hosp Epidemiol 1992; 13:599–605.Google Scholar
29. Olson, MM, Lee, JT Jr. Continuous, 10-year wound infection surveillance: results, advantages, and unanswered questions. Arch Surg 1990; 125:794–803.Google Scholar
30. Infection Prevention Working Party (WIP). Registration of hospital infections. Guideline 25b. Leiden: Leiden University Medical Center; 2001.Google Scholar
31. Hanley, JA, McNeil, BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29–36.Google Scholar
32. Cochrane Effective Practice and Organization of Care Group Web site. Available at: http://www.epoc.uottawa.ca/. Accessed March 2005.Google Scholar
33. Curtis, JJ, Boley, TM, Walls, JT, Hamory, B, Schmaltz, RA. Randomized, prospective comparison of first- and second-generation cephalosporins as infection prophylaxis for cardiac surgery. Am J Surg 1993; 166:734–737.Google Scholar
34. Salam, IM, Abu Galala, KH, el Ashaal, YI, Chandran, VP, Asham, NN, Sim, AJ. A randomized prospective study of cefoxitin versus piperacillin in appendicectomy. J Hosp Infect 1994; 26:133–136.Google Scholar
35. Jewesson, PJ, Stiver, G, Wai, A, et al. Double-blind comparison of cefazolin and ceftizoxime for prophylaxis against infections following elective biliary tract surgery. Antimicrob Agents Chemother 1996; 40:70–74.Google Scholar
36. Gillespie, WJ, Walenkamp, G. Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database Syst Rev 2001. CD000244.Google Scholar
37. Scher, KS. Studies on the duration of antibiotic administration for surgical prophylaxis. Am Surg 1997; 63:59–62.Google Scholar
38. Meijer, WS, Schmitz, PI, Jeekel, J. Meta-analysis of randomized, controlled clinical trials of antibiotic prophylaxis in biliary tract surgery. Br J Surg 1990; 77:283–290.Google Scholar
39. McDonald, M, Grabsch, E, Marshall, C, Forbes, A. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust NZJ Surg 1998; 68:388–396.Google Scholar
40. DiPiro, JT, Vallner, JJ, Bowden, TA Jr, Clark, BA, Sisley, JF. Intraoperative serum and tissue activity of cefazolin and cefoxitin. Arch Surg 1985; 120:829–832.CrossRefGoogle ScholarPubMed
41. Galandiuk, S, Polk, HC Jr, Jagelman, DG, Fazio, VW. Re-emphasis of priorities in surgical antibiotic prophylaxis. Surg Gynecol Obstet 1989; 169:219–222.Google Scholar
42. Gyssens, IC, Geerligs, IE, Nannini-Bergman, MG, Knape, JT, Hekster, YA, van der Meer, JW. Optimizing the timing of antimicrobial prophylaxis in surgery: an intervention study. J Antimicrob Chemother 1996; 38:301–308.Google Scholar
43. Schell, JA, Bynum, CG, Fortune, GJ, Laiben, GR, Chang, YJ, Pirner, JA. Perioperative antibiotics in nonemergency bowel surgery: a quality improvement project. South Med J 1998; 91:900–908.Google Scholar
44. Weinberg, M, Fuentes, JM, Ruiz, AI, et al. Reducing infections among women undergoing cesarean section in Colombia by means of continuous quality improvement methods. Arch Intern Med 2001; 161:2357–2365.Google Scholar